Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy
about
Mitochondrial Quality Control in Cardiac DiseasesThe Role of ERK1/2 in the Development of Diabetic CardiomyopathyBGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen SpeciesEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Potential Biochemical Mechanisms of Lung Injury in Diabetes.Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.Diabetes-Related Cardiac Dysfunction.New and revisited approaches to preserving the reperfused myocardium.Lung Ischaemia-Reperfusion Injury: The Role of Reactive Oxygen Species.Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts.IDH2 deficiency accelerates skin pigmentation in mice via enhancing melanogenesis.Oxidative stress measured in vivo without an exogenous contrast agent using QUEST MRI.Mito-TEMPO improves development competence by reducing superoxide in preimplantation porcine embryos.Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart FailureTargeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy
P2860
Q28072801-0DDD4D51-B153-4362-9EEB-C55A76F28321Q28075539-CB8620D1-91D2-4A46-BA63-0D4DFE4DDFF4Q28468438-0AC1E427-D0B4-4140-9719-3C2FAF20C74AQ33761211-D42EA514-5AD0-44C7-B5F0-8081DC3116D7Q38756917-5F67D34E-AB05-4BBB-B42A-BA738043E2A3Q39005762-EF964302-E5D3-416B-AC09-F4269438694DQ39418956-D0121113-45F2-40EB-9E6D-4385BB3E3104Q39420123-F3C5FDC4-DBD1-4BCA-B5E1-8F60A77C4225Q45064238-85224F0A-D76F-48C7-9F8A-C29DDC54A0FEQ46280862-57760CBC-0A8B-4206-B60B-A8EC000A0E79Q47813302-6DE59D86-BAB0-4ADB-BE79-5DC2500264B6Q51149358-9DA80891-6A02-4D08-AD5D-4D1117744BA3Q52320159-3381349A-4CED-486C-AE52-AD4491C32E9DQ55187240-109137A5-827B-4B06-8491-D7AA62DB22A0Q55689115-9988D86A-1DD5-44F7-890C-9847F1A9DEF7Q57095732-D090B6A1-7DEE-4E10-BED0-C742E7E69E0CQ58998162-E15EB278-AB27-4CD2-A9CE-891C55B17264
P2860
Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@ast
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@en
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@nl
type
label
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@ast
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@en
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@nl
prefLabel
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@ast
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@en
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@nl
P2093
P2860
P3181
P1476
Therapeutic inhibition of mito ...... educes diabetic cardiomyopathy
@en
P2093
Guo-Chang Fan
James C Lacefield
Sidong Xiong
Sydney Le Tissier
Tianqing Peng
Yanrong Lu
P2860
P3181
P356
10.1016/J.FREERADBIOMED.2015.11.013
P407
P577
2016-01-01T00:00:00Z